Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    22418699 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer
Conditions: Estrogen Receptor-positive Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Stage IV Breast Cancer
Interventions: Drug: anastrozole;   Drug: gefitinib;   Drug: fulvestrant;   Other: laboratory biomarker analysis

Study has passed its completion date and status has not been verified in more than two years.